Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1 2 or 4 weeks

Thumbnail Image

Files

Journal Article.pdf (2.28 MB)

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

WOS

URI

https://hdl.handle.net/10539/40941

Collections

Academic Wits Research Outputs (All submissions)

Endorsement

Review

Supplemented By

Referenced By